State Ledger
Company profile

Liminatus Pharma, Inc. CIK 1971387

Tickers
LIMN (Nasdaq) · LIMNW (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Cerritos, CA 90703
Fiscal year end
2025 (FY)
Market Data
Close
$3.55
Change
-$0.18
Change %
-4.70%
Volume
307

LIMN · trading date Oct 12, 2026 · previous close $3.73 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$10.21M
Total assets
$512.8K
Total liabilities
$10.33M
Stockholders' equity
-$9.81M
Cash & equivalents
—
Operating income
-$2.97M
Operating cash flow
-$9.96M
Capital expenditures
$13.1K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$9.98M
Free cash flow margin
—
Liabilities / assets
2,014.0%
Equity / assets
-1,914.0%
CapEx / revenue
—
Operating cash flow / net income
0.98×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$10.21M $512.8K $10.33M -$9.81M
2024 — -$3.55M $5.41M $24.75M -$19.34M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-18
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cerritos, CA 90703
12611 HIDDENCREEK WAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:20 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies